SECOND SIGHT MED PRODS INC's ticker is EYESXXXX and the CUSIP is 81362J100. A total of 43 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $89,000 | +641.7% | 15,000 | 0.0% | 0.00% | – |
| Q3 2019 | $12,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
| Q2 2019 | $12,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
| Q1 2019 | $12,000 | -7.7% | 15,000 | 0.0% | 0.00% | – |
| Q4 2018 | $13,000 | -55.2% | 15,000 | 0.0% | 0.00% | – |
| Q3 2018 | $29,000 | +16.0% | 15,000 | 0.0% | 0.00% | – |
| Q2 2018 | $25,000 | -13.8% | 15,000 | 0.0% | 0.00% | – |
| Q1 2018 | $29,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
| Q4 2017 | $29,000 | +61.1% | 15,000 | 0.0% | 0.00% | – |
| Q3 2017 | $18,000 | -5.3% | 15,000 | 0.0% | 0.00% | – |
| Q2 2017 | $19,000 | +5.6% | 15,000 | 0.0% | 0.00% | – |
| Q1 2017 | $18,000 | -40.0% | 15,000 | 0.0% | 0.00% | – |
| Q4 2016 | $30,000 | -43.4% | 15,000 | 0.0% | 0.00% | – |
| Q3 2016 | $53,000 | -1.9% | 15,000 | 0.0% | 0.00% | – |
| Q2 2016 | $54,000 | -25.0% | 15,000 | 0.0% | 0.00% | -100.0% |
| Q1 2016 | $72,000 | -18.2% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $88,000 | -1.1% | 15,000 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $89,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,492,975 | $3,597,974,000 | 1.05% |
| &PARTNERS | 51,961 | $42,000 | 0.06% |
| Glassman Wealth Services | 72,366 | $58,000 | 0.02% |
| Sigma Planning Corp | 385,737 | $309,000 | 0.02% |
| HBK Sorce Advisory LLC | 100,000 | $80,000 | 0.01% |
| Fore Capital, LLC | 56,300 | $45,000 | 0.01% |
| WealthTrust Axiom LLC | 17,320 | $13,000 | 0.01% |
| B. Riley Wealth Management, Inc. | 40,800 | $33,000 | 0.01% |
| Semmax Financial Advisors Inc. | 7,290 | $6,000 | 0.00% |
| Ausdal Financial Partners, Inc. | 10,025 | $9,000 | 0.00% |